He Y, Li K, Wang L, Sun Z, Cao Y, Li P
J Virol. 2021; 95(24):e0130821.
PMID: 34586859
PMC: 8610593.
DOI: 10.1128/JVI.01308-21.
Rangel G, Martin V, Barcena J, Blanco E, Alejo A
Pharmaceuticals (Basel). 2021; 14(7).
PMID: 34358101
PMC: 8308840.
DOI: 10.3390/ph14070675.
He Y, Li K, Cao Y, Sun Z, Li P, Bao H
PLoS Pathog. 2021; 17(4):e1009507.
PMID: 33909694
PMC: 8081260.
DOI: 10.1371/journal.ppat.1009507.
Shimmon G, Kotecha A, Ren J, Asfor A, Newman J, Berryman S
PLoS One. 2018; 13(8):e0201853.
PMID: 30114227
PMC: 6095514.
DOI: 10.1371/journal.pone.0201853.
Westerhuis B, Benschop K, Koen G, Claassen Y, Wagner K, Bakker A
J Virol. 2015; 89(15):7457-64.
PMID: 25948742
PMC: 4505642.
DOI: 10.1128/JVI.01079-15.
An increase in acid resistance of foot-and-mouth disease virus capsid is mediated by a tyrosine replacement of the VP2 histidine previously associated with VP0 cleavage.
Vazquez-Calvo A, Caridi F, Sobrino F, Martin-Acebes M
J Virol. 2013; 88(5):3039-42.
PMID: 24352460
PMC: 3958075.
DOI: 10.1128/JVI.03222-13.
Co-expression of the Bcl-xL antiapoptotic protein enhances the induction of Th1-like immune responses in mice immunized with DNA vaccines encoding FMDV B and T cell epitopes.
Iz S, Doskaya M, Borrego B, Rodriguez F, Guruz Y, Deliloglu Gurhan I
Vet Res Commun. 2013; 37(3):187-96.
PMID: 23483312
DOI: 10.1007/s11259-013-9560-3.
Plasma membrane phosphatidylinositol 4,5 bisphosphate is required for internalization of foot-and-mouth disease virus and vesicular stomatitis virus.
Vazquez-Calvo A, Sobrino F, Martin-Acebes M
PLoS One. 2012; 7(9):e45172.
PMID: 23028825
PMC: 3460999.
DOI: 10.1371/journal.pone.0045172.
Quasispecies as a matter of fact: viruses and beyond.
Ojosnegros S, Perales C, Mas A, Domingo E
Virus Res. 2011; 162(1-2):203-15.
PMID: 21945638
PMC: 7172439.
DOI: 10.1016/j.virusres.2011.09.018.
New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines.
Rodriguez-Calvo T, Ojosnegros S, Sanz-Ramos M, Garcia-Arriaza J, Escarmis C, Domingo E
PLoS One. 2010; 5(4):e10414.
PMID: 20454676
PMC: 2861626.
DOI: 10.1371/journal.pone.0010414.
A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition.
Martin-Acebes M, Rincon V, Armas-Portela R, Mateu M, Sobrino F
J Virol. 2010; 84(6):2902-12.
PMID: 20053737
PMC: 2826036.
DOI: 10.1128/JVI.02311-09.
Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner.
Goodwin S, Tuthill T, Arias A, Killington R, Rowlands D
J Virol. 2009; 83(21):11275-82.
PMID: 19710148
PMC: 2772760.
DOI: 10.1128/JVI.01263-09.
Biological effect of Muller's Ratchet: distant capsid site can affect picornavirus protein processing.
Escarmis C, Perales C, Domingo E
J Virol. 2009; 83(13):6748-56.
PMID: 19403672
PMC: 2698577.
DOI: 10.1128/JVI.00538-09.
Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3' noncoding region can elicit immunity in swine.
Pulido M, Sobrino F, Borrego B, Saiz M
J Virol. 2009; 83(8):3475-85.
PMID: 19211755
PMC: 2663259.
DOI: 10.1128/JVI.01836-08.
Emergence of a new strain of type O foot-and-mouth disease virus: its phylogenetic and evolutionary relationship with the PanAsia pandemic strain.
Hemadri D, Tosh C, Sanyal A, Venkataramanan R
Virus Genes. 2002; 25(1):23-34.
PMID: 12206305
DOI: 10.1023/a:1020165923805.
The foot and mouth disease virus type O outbreak of 1992 is not related to vaccine strain (O/R2/75).
Suryanarayana V, Tulasiram P, Prabhudas K, Misra L, Natarajan C
Virus Genes. 1998; 16(2):167-72.
PMID: 9608661
DOI: 10.1023/a:1007993606750.
A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation.
Verdaguer N, Sevilla N, Valero M, Stuart D, Brocchi E, Andreu D
J Virol. 1998; 72(1):739-48.
PMID: 9420281
PMC: 109430.
DOI: 10.1128/JVI.72.1.739-748.1998.
Efficient neutralization of foot-and-mouth disease virus by monovalent antibody binding.
Verdaguer N, Fita I, Domingo E, Mateu M
J Virol. 1997; 71(12):9813-6.
PMID: 9371652
PMC: 230296.
DOI: 10.1128/JVI.71.12.9813-9816.1997.
Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus.
Martinez M, Verdaguer N, Mateu M, Domingo E
Proc Natl Acad Sci U S A. 1997; 94(13):6798-802.
PMID: 9192645
PMC: 21238.
DOI: 10.1073/pnas.94.13.6798.
A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
Taboga O, Tami C, Carrillo E, Nunez J, Rodriguez A, Saiz J
J Virol. 1997; 71(4):2606-14.
PMID: 9060612
PMC: 191381.
DOI: 10.1128/JVI.71.4.2606-2614.1997.